ORIC Pharmaceuticals (ORIC) Stock Forecast & Price Target

$9.65

+0.17 (+1.79%)

(As of 09/6/2024 ET)

ORIC Pharmaceuticals - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Buy
Based on 7 Analyst Ratings

Based on 7 Wall Street analysts who have issued ratings for ORIC Pharmaceuticals in the last 12 months, the stock has a consensus rating of "Buy." Out of the 7 analysts, 7 have given a buy rating for ORIC.

Consensus Price Target

$18.00
86.53% Upside

High Forecast	$21.00
Average Forecast	$18.00
Low Forecast	$14.00

According to the 7 analysts' twelve-month price targets for ORIC Pharmaceuticals, the average price target is $18.00. The highest price target for ORIC is $21.00, while the lowest price target for ORIC is $14.00. The average price target represents a forecasted upside of 86.53% from the current price of $9.65.

Type	Current Forecast 9/8/23 to 9/7/24	1 Month Ago 8/9/23 to 8/8/24	3 Months Ago 6/10/23 to 6/9/24	1 Year Ago 9/8/22 to 9/8/23
Consensus Rating	Buy	Buy	Buy	Buy
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	7 Buy rating(s)	7 Buy rating(s)	6 Buy rating(s)	6 Buy rating(s)
Hold	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$18.00	$19.50	$20.00	$16.17
Forecasted Upside	86.53% Upside	84.78% Upside	69.66% Upside	157.40% Upside

Get ORIC Pharmaceuticals Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for ORIC and its competitors with MarketBeat's FREE daily newsletter.

Ad Porter & Company

The death of Nvidia?

Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S. housing… it's in artificial intelligence. And unless you know what’s really going on in this sector, you could be wiped out. You see, while there is no doubt that the recent advancements in artificial intelligence are game-changing and will drive colossal innovation in every sector of the economy... There's also no escaping that The Big AI Die-Up is coming.

So go here now to read my new report The Big AI Die-Up… while you still can.

ORIC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

ORIC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

ORIC Pharmaceuticals Stock vs. The Competition

Type	ORIC Pharmaceuticals	Medical Companies	S&P 500
Consensus Rating Score	3.00	2.77	2.51
Consensus Rating	Buy	Moderate Buy	Moderate Buy
Predicted Upside	86.53% Upside	1,206.56% Upside	11.36% Upside
News Sentiment Rating	Neutral News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Action	Rating	Price Target	Upside/Downside on Report Date
9/6/2024	Stifel Nicolaus 4 of 5 stars	Initiated Coverage	Buy	$20.00	+110.97%
8/14/2024	HC Wainwright 2 of 5 stars	Reiterated Rating	Buy ➝ Buy	$21.00 ➝ $21.00	+137.56%
8/13/2024	Oppenheimer 3 of 5 stars	Lower Target	Outperform ➝ Outperform	$17.00 ➝ $15.00	+81.16%
8/12/2024	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$20.00 ➝ $20.00	+141.55%
6/20/2024	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight
5/7/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Buy ➝ Buy	$15.00 ➝ $14.00	+44.93%
Get the Latest News and Ratings for ORIC and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for ORIC Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
3/27/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Overweight ➝ Overweight	$19.00 ➝ $18.00	+33.83%
8/16/2023	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Outperform ➝ Outperform	$15.00 ➝ $27.00	+209.28%
3/21/2023	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$15.00	+234.08%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 09:40 PM ET.

ORIC Forecast - Frequently Asked Questions

What is ORIC Pharmaceuticals' forecast for 2024?: According to the research reports of 7 Wall Street equities research analysts, the average twelve-month stock price forecast for ORIC Pharmaceuticals is $18.00, with a high forecast of $21.00 and a low forecast of $14.00.
Should I buy or sell ORIC Pharmaceuticals stock right now?: 7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for ORIC Pharmaceuticals in the last year. There are currently 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ORIC shares.
Does ORIC Pharmaceuticals's stock price have much upside?: According to analysts, ORIC Pharmaceuticals's stock has a predicted upside of 86.24% based on their 12-month stock forecasts.
What analysts cover ORIC Pharmaceuticals?: ORIC Pharmaceuticals has been rated by research analysts at Cantor Fitzgerald, HC Wainwright, Oppenheimer, Stifel Nicolaus, and Wedbush in the past 90 days.
Do Wall Street analysts like ORIC Pharmaceuticals more than its competitors?: Analysts like ORIC Pharmaceuticals more than other "medical" companies. The consensus rating for ORIC Pharmaceuticals is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how ORIC compares to other companies.